Holen Sie sich die Stockscreener-App
1.355
6.55%
-0.095
Handel nachbörslich:
1.36
0.005
+0.37%
Biorestorative Therapies Inc Aktie (BRTX) Neueste Nachrichten
BioRestorative Therapies Provides Business Update and Financial Results for Q3 2024 - Defense World
Analyzing American Caresource (OTCMKTS:GNOW) & BioRestorative Therapies (NASDAQ:BRTX) - Defense World
BioRestorative Therapies, Inc. (NASDAQ:BRTX) Q3 2024 Earnings Call Transcript - Insider Monkey
BioRestorative Therapies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
BioRestorative Therapies earnings beat by $0.31, revenue fell short of estimates - Investing.com Canada
BioRestorative Therapies Q3 2024 Financial Update - TipRanks
BioRestorative Therapies Lower Back Candidate Shows Decrease In Pain, Increased Function - Benzinga
BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data - OrthoSpineNews
BioRestorative's BRTX-100 Shows 100% Success Rate in Early Back Pain Trial Data | BRTX Stock News - StockTitan
BioRestorative Therapies Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire
BioRestorative Therapies Enters at-the-Market Offering Agreement with Rodman & Renshaw LLC - Defense World
Roth Capital Issues Optimistic Outlook for BRTX Earnings - Defense World
BioRestorative Therapies to Announce Phase 2 Trial Data - TipRanks
Research Analysts Offer Predictions for BRTX Q1 Earnings - Defense World
BioRestorative Therapies inks new equity deal - Investing.com
BioRestorative Therapies inks new equity deal By Investing.com - Investing.com UK
BRTXBioRestorative Therapies, Inc. Latest Stock News & Market Updates - StockTitan
BioRestorative Therapies to Present New Clinical Data at the ORS PSRS 7th International Spine Research Symposium - The Manila Times
BioRestorative to Present Expanded BRTX-100 Phase 2 Trial Data for Chronic Back Pain Treatment | BRTX Stock News - StockTitan
Broadrick Dale reduces stake in BioRestorative Therapies, Inc. with $1,756 sale - Investing.com
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health - GlobeNewswire
BioRestorative Therapies (OTCMKTS:BRTXQ) Reaches New 12-Month HighShould You Buy? - MarketBeat
BioRestorative Therapies Receives Patent Allowance for ThermoStem® Metabolic Disease Program - GlobeNewswire
BioRestorative Therapies (OTCMKTS:BRTXQ) Sets New 1-Year HighHere's Why - MarketBeat
BioRestorative Therapies (OTCMKTS:BRTXQ) Hits New 12-Month HighStill a Buy? - MarketBeat
BioRestorative Therapies to Participate in Upcoming UBS and Maxim Group Investor Events - GlobeNewswire
BioRestorative Therapies (OTCMKTS:BRTXQ) Sets New 52-Week HighWhat's Next? - MarketBeat
BioRestorative Therapies (OTCMKTS:BRTX) Stock Price Passes Below 50-Day Moving Average – Here’s Why - Defense World
BioRestorative Therapies to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference - GlobeNewswire
BioRestorative Therapies (OTCMKTS:BRTXQ) Sets New 1-Year High at $1.79 - Defense World
BioRestorative Therapies, Inc. (NASDAQ:BRTX) Short Interest Update - Defense World
BioRestorative Therapies (OTCMKTS:BRTXQ) Reaches New 12-Month High at $1.91 - Defense World
BioRestorative Therapies expands stock incentive plan - Investing.com
Acadian Asset Management LLC Sells 107,112 Shares of BioNTech SE (NASDAQ:BNTX) - MarketBeat
Biodexa Pharmaceuticals Announces ADR Ratio Change - TipRanks
Beasley Broadcast Group Approves Reverse Stock Split - RADIO ONLINE
BioLife Solutions (NASDAQ:BLFS) Stock Price Up 5.8% - MarketBeat
BioNTech Is More Than a Covid-19 Stock. It’s Having a Great September. - Barron's
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Bought by Meiji Yasuda Life Insurance Co - Defense World
Mutual of America Capital Management LLC Purchases Shares of 108,713 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World
Beasley Does a Reverse Stock Split - Radio World
Biomarin Pharmaceutical Inc. [BMRN] Shares Fall Approximately -19.71% Over the Year - Knox Daily
Daily Market Movement: BioNTech SE ADR (BNTX) Sees a -7.29 Decrease, Closing at 115.62 - The Dwinnex
Royal Bank of Canada Reiterates Outperform Rating for Biogen (NASDAQ:BIIB) - MarketBeat
BioLife Solutions (NASDAQ:BLFS) Shares Down 2% - Defense World
Beasley Broadcast Group’s Reverse Stock Split: What Shareholders Need to Know - TALKERS magazine
Massachusetts Financial Services Co. MA Boosts Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Banzai announces 1-for-50 reverse stock split - TipRanks
Beasley Media Group Implementing Reverse Stock Split. - Insideradio.com
BridgeBio Pharma (NASDAQ:BBIO) Shares Gap Up to $26.19 - Defense World
Bio-Rad Laboratories, Inc. (NYSE:BIO) Expected to Post Q3 2024 Earnings of $2.13 Per Share - MarketBeat
BioRestorative Therapies’ IFATS 2024 Presentation to Feature ThermoStem® Platform’s Potential to Deliver a Superior Efficacy and Tolerability Profile Over GLP-1 Drugs - GlobeNewswire
BioRestorative Therapies’ IFATS 2024 Presentation to - GlobeNewswire
Beyond Inc [BYON] stock for 97,352 USD was sold by Nettles William Benjamin JR - Knox Daily
BioNTech (NASDAQ:BNTX) Given New $131.00 Price Target at UBS Group - Defense World
Bosnian businessman launches buyout bid for Bihacka Pivovara - SeeNews
Bridger Aerospace group's interim CEO sells shares worth over $66k - Investing.com India
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):